Tenax Therapeutics (TENX) Receivables - Accured (2014 - 2021)
Tenax Therapeutics (TENX) posted quarterly Receivables - Accured of $4690.0 for Q2 2021, up 35.9% year-over-year from $3451.0 in Q2 2020, and up 39.71% on a QoQ basis from $3357.0 in Q1 2021.
Tenax Therapeutics (TENX) Receivables - Accured (2014 - 2021) Analysis & Trends
Tenax Therapeutics has reported Receivables - Accured for 8 years, with the latest figure at $4690.0 in Q2 2021.
- Receivables - Accured for Q2 2021 came in at $4690.0, up 35.9% year-over-year; the trailing twelve-month figure through Jun 2021 was $4690.0 (up 35.9% YoY), and the FY2020 annual result was $3551.0, up 32.15% from the prior year.
- Receivables - Accured climbed to $4690.0 in Q2 2021, from $3357.0 in the prior quarter.
- Over five years, Receivables - Accured peaked at $89425.0 in Q1 2017 and troughed at $2197.0 in Q4 2018.
- A 5-year average of $22879.6 and a median of $3573.5 in 2020 frame the typical range for Receivables - Accured.
- The widest annual swing landed in 2018, when Receivables - Accured sank 96.82%; it then soared 38.76% in 2020.
- A 5-year view of Receivables - Accured shows it stood at $69066.0 in 2017, then sank by 96.82% to $2197.0 in 2018, then gained by 22.3% to $2687.0 in 2019, then surged by 32.15% to $3551.0 in 2020, then jumped by 32.08% to $4690.0 in 2021.
- Per Business Quant data, the three most recent Receivables - Accured figures were $4690.0 in Q2 2021, $3357.0 in Q1 2021, and $3551.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 4,690.00 |
| Jun 30, 2021 | 4,690.00 |
| Mar 31, 2021 | 3,357.00 |
| Mar 31, 2021 | 3,357.00 |
| Dec 31, 2020 | 3,551.00 |
| Dec 31, 2020 | 3,551.00 |
| Sep 30, 2020 | 3,239.00 |
| Sep 30, 2020 | 3,239.00 |
| Jun 30, 2020 | 3,451.00 |
| Jun 30, 2020 | 3,451.00 |
| Mar 31, 2020 | 3,596.00 |
| Mar 31, 2020 | 3,596.00 |
| Dec 31, 2019 | 2,687.00 |
| Dec 31, 2019 | 2,687.00 |
| Sep 30, 2019 | 3,013.00 |
| Sep 30, 2019 | 3,013.00 |
| Jun 30, 2019 | 2,487.00 |
| Jun 30, 2019 | 2,487.00 |
| Mar 31, 2019 | 2,865.00 |
| Mar 31, 2019 | 2,865.00 |